Treatment Trends and Factors Associated with Survival in T1aN0 and T1bN0 Breast Cancer Patients

被引：0
|
作者：
Timothy Kennedy
Andrew K. Stewart
Karl Y. Bilimoria
Lina Patel-Parekh
Stephen F. Sener
David P. Winchester
机构：
[1] Feinberg School of Medicine,Department of Surgery
[2] American College of Surgeons,Commission on Cancer
[3] Evanston Northwestern Healthcare,Department of Surgery
来源：
Annals of Surgical Oncology | 2007年 / 14卷
关键词：
Brest cancer; National Cancer Data Base; Chemotherapy; Radiation; Hormonal therapy; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2918 / 2927
页数：9
相关论文
共 50 条
  • [1] Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients
    Kennedy, Timothy
    Stewart, Andrew K.
    Bilimoria, Karl Y.
    Patel-Parekh, Lina
    Sener, Stephen F.
    Winchester, David P.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (10) : 2918 - 2927
  • [2] Factors associated with treatment failure in T1aN0 and T1bN0 breast cancer patients
    Kennedy, TJ
    Patel-Parekh, L
    Stewart, A
    Winchester, DP
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 19 - 19
  • [3] Evaluation of treatment results in patients with early glottic cancer (stage T1aN0, T1bN0) treated with Manchester irradiation modality
    Przeorek, Wieslawa
    Skiadowski, Krzysztof
    Przeorek, Cezary
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2007, 11 (08): : 390 - 394
  • [4] Prognosis of T1bN0 breast cancer according to subtype: Korean Breast Cancer Registry Data
    Kang, Y-J.
    Oh, S. J.
    Choi, H.
    Cho, S.
    Shin, C-H.
    Kim, C.
    Kim, Y-S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S316 - S317
  • [5] Do 21-Gene Recurrence Score Influence Chemotherapy Decisions in T1bN0 Breast Cancer Patients?
    Yu, Jing
    Wu, Jiayi
    Huang, Ou
    He, Jianrong
    Li, Zhu
    Chen, Weiguo
    Li, Yafen
    Chen, Xiaosong
    Shen, Kunwei
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] Favorable Prognosis in Patients With T1a/T1bN0 Triple-Negative Breast Cancers Treated With Multimodality Therapy
    Ho, Alice Y.
    Gupta, Gaorav
    King, Tari A.
    Perez, Carmen A.
    Patil, Sujata M.
    Rogers, Katherine H.
    Wen, Yong Hannah
    Brogi, Edi
    Morrow, Monica
    Hudis, Clifford A.
    Traina, Tiffany
    McCormick, Beryl
    Powell, Simon N.
    Robson, Mark E.
    [J]. CANCER, 2012, 118 (20) : 4944 - 4952
  • [7] Clinical Features and Survival Analysis of T1mic, a, bN0M0 Breast Cancer
    Li, Junnan
    Liu, Xiaodong
    Tong, Zhongsheng
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (06) : 471 - 476
  • [8] The Value of OncotypeDX (oDX) Testing in Patients with T1aN0 Hormone Receptor (HR) (+) Breast Cancer
    Malinovitch, Angela
    Goldbach, Macy
    Pomponio, Maria
    Burkbauer, Laura
    Keele, Luke
    Nazarian, Susanna
    Rothman, Jami
    Tchou, Julia
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S472 - S473
  • [9] Evaluating Organ Preservation Outcome as Treatment Endpoint for T1aN0 Glottic Cancer
    Low, Tsu-Hui
    Yeh, David
    Zhang, Tina
    Araslanova, Rakhna
    Hammond, J. Alex
    Palma, David
    Read, Nancy
    Venkatesan, Varagur
    MacNeil, S. Danielle
    Yoo, John
    Nichols, Anthony
    Fung, Kevin
    [J]. LARYNGOSCOPE, 2017, 127 (06): : 1322 - 1327
  • [10] Prognosis of T1bN0M0 breast cancer in patients receiving breast conservation therapy.
    VanderVelde, N
    Decker, DA
    Vicini, F
    Mitchell, C
    Huang, R
    Zakalik, D
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 266 - 266
12345